{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:59:03Z","timestamp":1772762343583,"version":"3.50.1"},"reference-count":19,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1954,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1111\/j.1600-0404.2010.01354.x","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T13:00:37Z","timestamp":1272286837000},"page":"295-302","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy and safety of NT\u2003201 for upper limb spasticity of various etiologies - a randomized parallel-group study"],"prefix":"10.1155","volume":"122","author":[{"given":"M.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lehnert-Batar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Minnasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2010,4,26]]},"reference":[{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB1|cit1","first-page":"148","volume-title":"Botulinum toxin - therapeutic clinical practice and science","author":"Elia","year":"2009"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","article-title":"Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2340\/16501977-0303","article-title":"European consensus table on the use of botulinum toxin type A in adult spasticity","volume":"41","author":"Wissel","year":"2009","journal-title":"J Rehabil Med"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00702-004-0234-8","article-title":"Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT\u2003201) compared with commercially available botulinum toxin type A (BOTOX\u00ae) in healthy volunteers","volume":"112","author":"Jost","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.WNF.0000240951.18821.50","article-title":"Neurophysiological double-blind trial of a botulinum neurotoxin type A free of complexing proteins","volume":"30","author":"Wohlfarth","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia","volume":"64","author":"Benecke","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm","volume":"113","author":"Roggenk\u00e4mper","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNF.0b013e3181b13308","article-title":"Efficacy and safety of botulinum neurotoxin NT\u2003201 in post-stroke upper limb spasticity","volume":"32","author":"Ka\u00f1ovsk\u00fd","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB9|cit9","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1053\/apmr.2002.35474","article-title":"Inter- and intra-rater reliability of the Ashworth scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity","volume":"83","author":"Brashear","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB11|cit11","unstructured":"WE MOVE. BTX-A (BOTOX\u00ae) Adult dosing guidelines for the management of spasticity http:\/\/www.mdvu.org\/library\/dosingtables\/"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-200767050-00003","article-title":"Botulinum neurotoxin type A free of complexing proteins (XEOMIN\u00ae) in focal dystonia","volume":"67","author":"Jost","year":"2007","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.22452","article-title":"Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review","volume":"24","author":"Elia","year":"2009","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.apmr.2003.08.077","article-title":"Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial","volume":"85","author":"Brashear","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.apmr.2008.01.007","article-title":"Repeated treatments with botulinum toxin type A produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients","volume":"89","author":"Elovic","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002060-200205000-00007","article-title":"Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques","volume":"81","author":"Francisco","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/j.1600-0404.2010.01354.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.apmr.2006.02.015","article-title":"Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity","volume":"87","author":"Turkel","year":"2006","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2010.01354.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2010.01354.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:48:27Z","timestamp":1671540507000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2010.01354.x"}},"subtitle":["NT\u2003201 in upper limb spasticity"],"short-title":[],"issued":{"date-parts":[[2010,4,26]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01354.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4,26]]}}}